课题基金 / 基金详情

CLINICAL TRIAL: MYCOPHENOLATE MOFETIL IN PATIENTS WITH 1GA NEPHROPATHY

CLINICAL TRIAL: MYCOPHENOLATE MOFETIL IN PATIENTS WITH 1GA NEPHROPATHY
临床试验:霉酚酸酯用于 1GA 肾病患者
批准号:
7716776
负责人:
DEBBIE S GIPSON
金额:
$0.05万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-02 至 2008-05-31

项目摘要

项目成果

DEBBIE S GIPSON的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是测试一种名为霉酚酸酯(MMF)的药物,看看它是否有助于控制肾脏疾病1gA肾病。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to test a medication called Mycophenolate Mofetil (MMF) to see if it helps to control the kidney disease 1gA Nephropathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preparing a clinical outcomes assessment set for nephrotic syndrome [Prepare-NS]
Preparing a clinical outcomes assessment set for nephrotic syndrome [Prepare-NS]
GDPrime
GDPrime